Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2012 15:57 ET | Source: Boston Therapeutics, Inc.

Boston Therapeutics Corporate Update

MANCHESTER, NH--(Marketwire - Apr 2, 2012) - Boston Therapeutics Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, reviews the series of events that have led to the availability of its lead...
March 02, 2012 17:13 ET | Source: Boston Therapeutics, Inc.

Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board

MANCHESTER, NH--(Marketwire - Mar 2, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased to announce that it has received clearance by FINRA on...
January 24, 2012 11:40 ET | Source: Boston Therapeutics, Inc.

Boston Therapeutics Announces Clinical Study Safety Results With SUGARDOWN(R) at University of Sydney

MANCHESTER, N.H., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc. (BTI), a developer of diabetes therapeutics, announced today the clinical trial results in healthy volunteers performed at...